newsfilter
← Latest News
Business Wire·

Auna Announces 4Q25 and FY25 Financial Results

  • Auna closed fiscal year 2025 with revenue increasing 4% FXN to S/4,385 million & flat on a reported basis.
  • Adjusted EBITDA for FY25 decreased 3% FXN to S/917 million, while Adjusted Net Income rose to S/336 million from S/146 million in FY24.
  • Free Cash Flow increased 35% YoY in FY25, supported by strict cost management & enhanced working capital.
  • Operating Cash Flow increased 2% YoY in FY25.
  • Oncology Medical Loss Ratio (MLR) improved to a record low of 48.5% in FY25, down from 53.0% in FY24.
  • Peru & Colombia delivered solid performance in FY25, while Mexico faced challenges before showing recovery signs in late 2025 & early 2026.
  • Mexico operations stabilized in 4Q25 & the first two months of 2026, with new leadership & favorable insurance tier classifications driving early results.
  • Colombia expanded risk-sharing models to 21% of segment revenue in 4Q25, covering approximately 3 million protected lives.
  • Peru secured authorization to refurbish & open Centro Ambulatorio Trecca in Lima by 2028, aiming to serve up to 3 million EsSalud beneficiaries annually.
  • Auna completed a US$825 million refinancing to reduce interest expenses, extend maturity, & increase local currency funding.
  • Net leverage remained stable at 3.6x at the end of FY25, with a commitment to reduce it below 3x over the medium term.
  • The company set FY26 guidance for 12% FXN revenue & Adjusted EBITDA growth, within a range of 10% to 14%.
  • FY26 capital expenditures are expected to remain at approximately 4% of revenues.
  • Reported results were impacted by foreign exchange fluctuations, including a 1% MXN depreciation & 3% COP appreciation against the PEN.
  • Net Loss was S/64 million in 4Q25, contrasting with a S/24 million net gain in 4Q24, while FY25 Net Income was S/111 million.
  • Adjusted Net Income reached S/136 million in 4Q25 & S/336 million for FY25.
  • Auna plans to hold a conference call on March 11, 2026, at 8:00 a.m. Eastern time to discuss results.